Monthly Archives: May 2020

New Treatment for Thyroid Eye Disease

Thyroid eye disease (TED, also known as Graves’ disease) is an autoimmune  inflammatory disease, sometimes causing red or bulging eyes, sometimes causing double or reduced vision. While often associated with an overactive thyroid, some TED patients have normal thyroid function. Some TEA patients have mild changes – slight eyelid retraction or puffiness, for example. However,… Read More


Another Reason for A Good Night’s Sleep 

  If your upper airway collapses during sleep, you may suffer from more than a snoring problem.  Obstructive sleep apnea has been strongly associated with high blood pressure, heart attack, and stroke. A recent study from Australia (Ophthalmology, 2019;126:1372) supports a connection between sleep apnea and glaucoma in young adults. The research project measured the… Read More


Now Offering Telemedicine!


Retinoblastoma

Retinoblastoma is the most common primary ocular malignancy in children, and until recently was a major cause of childhood blindness, and, occasionally, death.  In the last two decades, major advances in chemotherapy, delivered directly to the eye, have reduced the need for systemic chemotherapy, while maintaining good survival rates as well as  eye / vision… Read More


First Approved Peanut Allergy Treatment for Children

  The FDA has approved the first oral treatment for peanut allergy in children aged 4 to 17 years.  Palforzia (manufactured by Aimmune Therapeutics) is a powder made from peanuts, consumed by patient in a macrodosing regimen spread over several months. At present the medication is only available through a special FDA Risk Evaluation and… Read More